Edition:
United Kingdom

Aevi Genomic Medicine Inc (GNMX.OQ)

GNMX.OQ on NASDAQ Stock Exchange Global Market

1.16USD
17 Aug 2018
Change (% chg)

$0.04 (+3.57%)
Prev Close
$1.12
Open
$1.14
Day's High
$1.16
Day's Low
$1.09
Volume
29,758
Avg. Vol
22,927
52-wk High
$2.64
52-wk Low
$0.84

Latest Key Developments (Source: Significant Developments)

Aevi Genomic Lead Molecule Expected To Have Composition Of Matter Patents Extending To 2039
Thursday, 19 Jul 2018 

July 19 (Reuters) - Aevi Genomic Medicine Inc ::AEVI GENOMIC MEDICINE, INC. ANNOUNCES NOVEL CO-CRYSTAL VERSION OF AEVI-001.AEVI GENOMIC MEDICINE - RECEIVED POSITIVE FEEDBACK FROM FDA ON IMPROVED VERSION OF LEAD DEVELOPMENT MOLECULE, AEVI-001, IDENTIFIED AS AEVI-004.AEVI GENOMIC MEDICINE INC - AEVI-004 IS EXPECTED TO HAVE COMPOSITION OF MATTER PATENTS EXTENDING TO 2039.AEVI GENOMIC MEDICINE - SEES PROGRESSING MOLECULE DIRECTLY INTO PHASE 3 STUDIES WITH MINIMAL IMPACT ON PROGRAM TIMELINE.AEVI GENOMIC MEDICINE INC - FDA PROVISIONALLY AGREED THAT AEVI-004 IS A CO-CRYSTAL AND A NOVEL DRUG SUBSTANCE.  Full Article

Aevi Genomic Medicine Files For Mixed Shelf Of Up To $50 Mln
Tuesday, 15 May 2018 

May 15 (Reuters) - Aevi Genomic Medicine Inc ::AEVI GENOMIC MEDICINE INC FILES FOR MIXED SHELF OF UP TO $50 MILLION – SEC FILING.  Full Article

Aevi Genomic Medicine Q1 Loss Per Share $0.15
Tuesday, 15 May 2018 

May 15 (Reuters) - Aevi Genomic Medicine Inc ::AEVI GENOMIC MEDICINE REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE.Q1 LOSS PER SHARE $0.15.Q1 EARNINGS PER SHARE VIEW $-0.14 -- THOMSON REUTERS I/B/E/S.CASH AND CASH EQUIVALENTS OF $26.52 MILLION AT MARCH 31, 2018, COMPARED TO $33.73 MILLION AS OF DECEMBER 31, 2017.EXPECTS CURRENT CASH BALANCE TO FUND OPERATIONS INTO EARLY 2019.  Full Article

Aevi Genomic Medicine Files For Resale Of Up To 26.2 Mln Shares Of Co's Common Stock By Selling Stockholders
Friday, 8 Dec 2017 

Dec 8 (Reuters) - Aevi Genomic Medicine Inc ::AEVI GENOMIC MEDICINE INC FILES FOR RESALE OF UP TO 26.2 MILLION SHARES OF CO'S COMMON STOCK BY SELLING STOCKHOLDERS - SEC FILING.  Full Article

Aevi Genomic Medicine Q3 loss per share $0.23
Thursday, 2 Nov 2017 

Nov 2 (Reuters) - Aevi Genomic Medicine Inc ::Aevi Genomic Medicine reports third quarter 2017 financial results.Q3 loss per share $0.23.Q3 earnings per share view $-0.22 -- Thomson Reuters I/B/E/S.Aevi Genomic Medicine Inc - ‍company had cash and cash equivalents of $14.96 million at September 30, 2017​.Aevi Genomic Medicine Inc- ‍expects current cash balance, including proceeds from pipe offering, to fund operations into early 2019​.  Full Article

BRIEF-Aevi Genomic Medicine Files For Mixed Shelf Of Up To $50 Mln

* AEVI GENOMIC MEDICINE INC FILES FOR MIXED SHELF OF UP TO $50 MILLION – SEC FILING Source text: (https://bit.ly/2IjWI5B) Further company coverage: